Literature DB >> 1819488

Regulation of transformation and the cell cycle by p53.

G P Zambetti1, R S Quartin, J Martinez, I Georgoff, J Momand, D Dittmer, C A Finlay, A J Levine.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1819488     DOI： 10.1101/sqb.1991.056.01.027

Source DB:  PubMed          Journal:  Cold Spring Harb Symp Quant Biol        ISSN： 0091-7451


× No keyword cloud information.
  5 in total

1.  Differential regulation of the overlapping Kaposi's sarcoma-associated herpesvirus vGCR (orf74) and LANA (orf73) promoters.

Authors:  J Jeong; J Papin; D Dittmer
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

2.  Inhibition of DNA topoisomerase II alpha gene expression by the p53 tumor suppressor.

Authors:  Q Wang; G P Zambetti; D P Suttle
Journal:  Mol Cell Biol       Date:  1997-01       Impact factor: 4.272

3.  Effects of mutant p53 expression on human 15-lipoxygenase-promoter activity and murine 12/15-lipoxygenase gene expression: evidence that 15-lipoxygenase is a mutator gene.

Authors:  U P Kelavkar; K F Badr
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-13       Impact factor: 11.205

4.  ATM and the catalytic subunit of DNA-dependent protein kinase activate NF-kappaB through a common MEK/extracellular signal-regulated kinase/p90(rsk) signaling pathway in response to distinct forms of DNA damage.

Authors:  Ganesh R Panta; Swayamjot Kaur; Lakita G Cavin; Maria L Cortés; Frank Mercurio; Leonard Lothstein; Trevor W Sweatman; Mervyn Israel; Marcello Arsura
Journal:  Mol Cell Biol       Date:  2004-03       Impact factor: 4.272

5.  The TP53 Codon 72 Polymorphism and Risk of Sporadic Prostate Cancer among Iranian Patients.

Authors:  Farhad Babaei; Seyed Ali Ahmadi; Ramin Abiri; Farhad Rezaei; Maryam Naseri; Mahmoud Mahmoudi; Rakhshande Nategh; Talat Mokhtari Azad
Journal:  Iran J Public Health       Date:  2014-04       Impact factor: 1.429
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.